Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2019-09-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
第七届监事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the resolutions passed at the 25th meeting of the 7th Supervisory Board. It includes details about the nomination of candidates for the 8th Supervisory Board, their resumes, and the approval of supervisory board member allowances. The document is a meeting resolution announcement related to board/management changes, specifically about the supervisory board members. It does not contain financial statements, audit results, or earnings data. It is not a report publication announcement or a certification. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters and contains detailed information about board member nominations and allowances, confirming it is a management-related announcement rather than a report or regulatory filing.
2019-09-27 Chinese
独立董事候选人声明（谷杨）
Board/Management Information Classification · 100% confidence The document is a formal declaration by an independent director candidate (谷杨) of Shenzhen Haier Bioengineering Co., Ltd. It contains detailed statements about the candidate's qualifications, independence, compliance with various regulatory requirements, and legal declarations related to the role of an independent director. There are no financial statements, earnings data, or management discussion of financial results. The document is not an announcement of a report but a standalone declaration related to board/management information. This fits the category of Board/Management Information (MANG), as it concerns the appointment and qualifications of a board member.
2019-09-27 Chinese
第七届董事局第三十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Shenzhen Haiwang Bioengineering Co., Ltd. It includes information about changes to the company's articles of association and board rules, nominations and biographies of new board members (both independent and non-independent directors), and details about director remuneration. The document also mentions the need for shareholder approval for these resolutions. There is no financial data, earnings information, or audit content. The focus is on board composition, governance structure, and management appointments. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length (8123 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive governance-related announcement. Therefore, the correct classification is MANG with high confidence.
2019-09-27 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement regarding the nomination of an independent director candidate for the company's board. It details the nominee's qualifications, compliance with various regulatory requirements, and declarations about independence and eligibility. There is no financial data, no mention of financial results, no voting results, no meeting materials, and no legal proceedings. The content is focused on board/management information, specifically about a director nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (6863 characters) supports it being a full statement rather than a brief announcement or certification.
2019-09-27 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement by the nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with laws and regulations, and independence of the nominee. There is no financial data, no mention of financial results, no report publication, or voting results. The content is focused on board/management information, specifically about a board nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive about management changes, not just an announcement or regulatory filing.
2019-09-27 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement by the nominating party regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and independence criteria of the nominee. There is no financial data, no discussion of financial results, no mention of shareholder voting results, or any other report type. The content is focused on board/management information, specifically about a director nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement or certification.
2019-09-27 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.